Qutorin pitavastatin
搜索文档
Palvella Therapeutics (NasdaqCM:PVLA) 2025 Conference Transcript
2025-11-13 06:00
Palvella Therapeutics (NasdaqCM:PVLA) 2025 Conference November 12, 2025 04:00 PM ET Speaker1All right, good afternoon, everyone, and welcome to the Palvella Therapeutics session. It's our pleasure to have CEO Wes Kaupinen presenting for us today. Thanks for coming. Palvella has certainly moved pretty rapidly from, I would say, a little-known name to probably one of the most broadly covered names in very rapid succession here. Your stock is up 500% plus. That's kind of cool. For anyone who doesn't quite know ...